These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20071638)

  • 21. Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment.
    Gürkan K; Bilgiç A; Türkoglu S; Kiliç BG; Aysev A; Uslu R
    J Psychopharmacol; 2010 Dec; 24(12):1810-8. PubMed ID: 19939861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management.
    Goodman DW; Thase ME
    Postgrad Med; 2009 Sep; 121(5):20-30. PubMed ID: 19820271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder.
    Ratner S; Laor N; Bronstein Y; Weizman A; Toren P
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):428-33. PubMed ID: 15843764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
    Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
    Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW; Earl CQ; Arora S
    Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seasonality of mood disorders in adults with lifetime attention-deficit/hyperactivity disorder (ADHD).
    Amons PJ; Kooij JJ; Haffmans PM; Hoffman TO; Hoencamp E
    J Affect Disord; 2006 Apr; 91(2-3):251-5. PubMed ID: 16458365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do micronutrients help in ADHD?
    Tondo L
    Br J Psychiatry; 2015 Nov; 207(5):460. PubMed ID: 26527669
    [No Abstract]   [Full Text] [Related]  

  • 30. Could yeast infections impair recovery from mental illness? A case study using micronutrients and olive leaf extract for the treatment of ADHD and depression.
    Rucklidge JJ
    Adv Mind Body Med; 2013; 27(3):14-8. PubMed ID: 23784606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring quality of life in adults with ADHD: reliability and validity of a new measure.
    Landgraf JM
    J Atten Disord; 2007 Nov; 11(3):351-62. PubMed ID: 17494834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Massage therapy improves mood and behavior of students with attention-deficit/hyperactivity disorder.
    Khilnani S; Field T; Hernandez-Reif M; Schanberg S
    Adolescence; 2003; 38(152):623-38. PubMed ID: 15053490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin-Mineral Treatment of ADHD in Adults.
    Rucklidge JJ; Frampton CM; Gorman B; Boggis A
    J Atten Disord; 2017 Apr; 21(6):522-532. PubMed ID: 24804687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of attention-deficit-hyperactivity disorder symptoms, depressive/anxiety symptoms, and life quality in young men.
    Chao CY; Gau SS; Mao WC; Shyu JF; Chen YC; Yeh CB
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):421-6. PubMed ID: 18778439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-reported childhood attention-deficit/hyperactivity disorder symptoms are not specific to the disorder.
    Suhr J; Zimak E; Buelow M; Fox L
    Compr Psychiatry; 2009; 50(3):269-75. PubMed ID: 19374973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention-deficit/hyperactivity disorder in adults: recognition and diagnosis of this often-overlooked condition.
    Feifel D; MacDonald K
    Postgrad Med; 2008 Sep; 120(3):39-47. PubMed ID: 18824824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study.
    Biederman J; Monuteaux MC; Mick E; Spencer T; Wilens TE; Silva JM; Snyder LE; Faraone SV
    Psychol Med; 2006 Feb; 36(2):167-79. PubMed ID: 16420713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of micronutrient supplementation on mood in nursing home residents.
    Gosney MA; Hammond MF; Shenkin A; Allsup S
    Gerontology; 2008; 54(5):292-9. PubMed ID: 18463429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-label trial of atomoxetine hydrochloride in adults with ADHD.
    Johnson M; Cederlund M; Råstam M; Areskoug B; Gillberg C
    J Atten Disord; 2010 Mar; 13(5):539-45. PubMed ID: 19458384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emotional dysregulation in adult ADHD and response to atomoxetine.
    Reimherr FW; Marchant BK; Strong RE; Hedges DW; Adler L; Spencer TJ; West SA; Soni P
    Biol Psychiatry; 2005 Jul; 58(2):125-31. PubMed ID: 16038683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.